Clinical challenges: The intersection of diabetes, chronic kidney disease, and cardiovascular disease Caitlin M. NassKim Reck Invited Commentary Pages: 1 - 2
Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus Ian J. Sarembock OriginalPaper Pages: 13 - 19
The role of electron beam computed tomography for measuring coronary artery atherosclerosis Theodore Mazzone OriginalPaper Pages: 20 - 25
Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus? Sherita Hill GoldenRachel Chong OriginalPaper Pages: 26 - 30
The role of advanced glycation end products in the development of atherosclerosis Melpomeni PeppaJaime UribarriHelen Vlassara OriginalPaper Pages: 31 - 36
BNP levels to screen for left ventricular dysfunction Neelima V. ChuSteven V. Edelman Clinical Trials Report Pages: 39 - 40
Hyperglycemia with antipsychotic treatment Roopa SathyaprakashRobert R. Henry OriginalPaper Pages: 41 - 45
The metabolic syndrome in children and adolescents Martha L. CruzMichael I. Goran OriginalPaper Pages: 53 - 62
Cardiovascular risk associated with the metabolic syndrome Robert S. LindsayBarbara V. Howard OriginalPaper Pages: 63 - 68
Treatment of PCOS with metformin and other insulin-sensitizing agents Emre SeliAntoni J. Duleba OriginalPaper Pages: 69 - 75